Adam W Carrico1, Sarah E Woolf-King2, Torsten B Neilands2, Samantha E Dilworth2, Mallory O Johnson3. 1. University of California, San Francisco, School of Nursing, United States; University of California, San Francisco, Center for AIDS Prevention Studies (CAPS), United States. Electronic address: adam.carrico@ucsf.edu. 2. University of California, San Francisco, Center for AIDS Prevention Studies (CAPS), United States. 3. University of California, San Francisco, School of Nursing, United States; University of California, San Francisco, Center for AIDS Prevention Studies (CAPS), United States; University of California, San Francisco, School of Pharmacy, United States.
Abstract
BACKGROUND: Research conducted to date has focused primarily on identifying individual-level, psychological determinants of stimulant use and HIV disease management. The present cross-sectional study examined relationship factors as correlates of stimulant use and HIV disease management among men who have sex with men (MSM). METHODS: In total, 266 male couples completed a baseline assessment for a cohort study examining the role of relationship factors in HIV treatment. A computer-based assessment of relationship factors, self-reported alcohol and substance use, and self-reported anti-retroviral therapy (ART) adherence was administered. All HIV-positive participants also provided a blood sample to measure viral load. RESULTS: After controlling for demographic characteristics and relationship factors, men in a primary relationship with a stimulant-using partner had more than six-fold greater odds of reporting any stimulant use in the past three months. Among HIV-positive participants on ART (n=371), having a stimulant-using partner was independently associated with 67% lower odds of reporting perfect 30-day ART adherence and more than two-fold greater odds of displaying a detectable HIV viral load. In contrast, more partner-level alcohol use was independently associated with greater odds of reporting perfect 3-day ART adherence and lower odds of displaying a detectable HIV viral load. CONCLUSIONS: Partner-level stimulant use is an important risk factor for individual-level stimulant use and difficulties with HIV disease management among MSM. To optimize the effectiveness of HIV treatment as prevention, clinical research is needed to develop couples-based interventions targeting stimulant use as a potential driver of detectable HIV viral load.
BACKGROUND: Research conducted to date has focused primarily on identifying individual-level, psychological determinants of stimulant use and HIV disease management. The present cross-sectional study examined relationship factors as correlates of stimulant use and HIV disease management among men who have sex with men (MSM). METHODS: In total, 266 male couples completed a baseline assessment for a cohort study examining the role of relationship factors in HIV treatment. A computer-based assessment of relationship factors, self-reported alcohol and substance use, and self-reported anti-retroviral therapy (ART) adherence was administered. All HIV-positive participants also provided a blood sample to measure viral load. RESULTS: After controlling for demographic characteristics and relationship factors, men in a primary relationship with a stimulant-using partner had more than six-fold greater odds of reporting any stimulant use in the past three months. Among HIV-positive participants on ART (n=371), having a stimulant-using partner was independently associated with 67% lower odds of reporting perfect 30-day ART adherence and more than two-fold greater odds of displaying a detectable HIV viral load. In contrast, more partner-level alcohol use was independently associated with greater odds of reporting perfect 3-day ART adherence and lower odds of displaying a detectable HIV viral load. CONCLUSIONS: Partner-level stimulant use is an important risk factor for individual-level stimulant use and difficulties with HIV disease management among MSM. To optimize the effectiveness of HIV treatment as prevention, clinical research is needed to develop couples-based interventions targeting stimulant use as a potential driver of detectable HIV viral load.
Authors: Mallory O Johnson; Samantha E Dilworth; Jonelle M Taylor; Lynae A Darbes; Megan L Comfort; Torsten B Neilands Journal: AIDS Behav Date: 2012-08
Authors: Fabian Termorshuizen; Anneke Krol; Maria Prins; Ronald Geskus; Wim van den Brink; Erik J C van Ameijden Journal: Drug Alcohol Depend Date: 2005-02-24 Impact factor: 4.492
Authors: Anna Azevedo Simoes; Francisco Inacio Bastos; Ronaldo Ismerio Moreira; Kevin G Lynch; David S Metzger Journal: J Subst Abuse Treat Date: 2006-04
Authors: Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall Journal: Lancet Date: 2010-07-16 Impact factor: 79.321
Authors: Pamina M Gorbach; Lydia N Drumright; Marjan Javanbakht; Sergei L Pond; Christopher H Woelk; Eric S Daar; Susan J Little Journal: J Acquir Immune Defic Syndr Date: 2008-04-15 Impact factor: 3.731
Authors: John Christopher Walsh; Anton Louis Pozniak; Mark Richard Nelson; Sundhiya Mandalia; Brian George Gazzard Journal: J Acquir Immune Defic Syndr Date: 2002-07-01 Impact factor: 3.731
Authors: Matthew J Mimiaga; David W Pantalone; Katie B Biello; Jackie M White Hughto; John Frank; Conall O'Cleirigh; Sari L Reisner; Arjee Restar; Kenneth H Mayer; Steven A Safren Journal: AIDS Care Date: 2019-03-19
Authors: Kristi E Gamarel; Sarah E Woolf-King; Adam W Carrico; Torsten B Neilands; Mallory O Johnson Journal: J Acquir Immune Defic Syndr Date: 2015-02-01 Impact factor: 3.731
Authors: Arpi Minassian; Brook L Henry; Jennifer E Iudicello; Erin E Morgan; Scott L Letendre; Robert K Heaton; William Perry Journal: Drug Alcohol Depend Date: 2017-03-28 Impact factor: 4.492
Authors: Adam W Carrico; Roland Zepf; Steven Meanley; Abigail Batchelder; Ronald Stall Journal: J Acquir Immune Defic Syndr Date: 2016-11-01 Impact factor: 3.731
Authors: S A Meyers-Pantele; H J Rendina; A J Talan; O Shalhav; S Lammert; K J Horvath Journal: Drug Alcohol Depend Date: 2021-07-28 Impact factor: 4.852
Authors: Uma Sriram; Beth L Hill; Jonathan M Cenna; Larisa Gofman; Nicole C Fernandes; Bijayesh Haldar; Raghava Potula Journal: PLoS One Date: 2016-10-19 Impact factor: 3.240